Lapatinib Completed Phase 2 Trials for Stage IV Breast Cancer / Male Breast Cancer / Tumors Metastatic to Brain / Her2-Positive Breast Cancer / Recurrent Breast Cancer / Central Nervous System Metastases Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00098605Lapatinib in Treating Brain Metastases in Patients With Stage IV Breast Cancer and Brain Metastases